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Introduction
The ETV6 (ETS variant 6), also known as TEL1 (translocating
E26 transforming-specific leukemia 1), gene encodes a nuclear
phosphoprotein belonging to the ETS family of transcription
factors, which collectively play important roles in a diverse
range of cellular processes, including proliferation, differentia-
tion, apoptosis and transformation.1 ETV6 is widely expressed
during embryonic development, with higher levels of expres-
sion observed in the developing kidney, liver and lung, as well
as the cranial nerve ganglia, dorsal root ganglia and the ventral
region of the caudal neural tube,2 and shows broad expression
in the adult, including in various hematopoietic cells.2 Like
other ETS family members, ETV6 possesses two conserved
domains: a PNT (pointed) or HLH (helix-loop-helix) domain at
its N-terminus and an ETS domain at its C-terminus, and has
been identified as a strong transcriptional repressor.3,4 The PNT
domain is responsible for both homodimerization and het-
erodimerization with a range of proteins, including the closely-
related ETV7 (TEL2) protein, the ETS family member FLI1 and
the ubiquitin-conjugating enzyme UBC90.4-6 This domain is
required for the repression of target genes,5 and also mediates
the nuclear export of ETV6, thereby regulating its activity.7 The
positively charged ETS domain is responsible for binding to
purine rich segments of DNA, recognizing a core GGAA/T
sequence.8 A less conserved central domain contributes to the
strong repressional activity of ETV6 through binding of various
co-repressors, including mSin3A, SMRT, and N-CoR, which
subsequently recruit histone deacetylases to mediate transcrip-
tional repression.4,9,10
The human ETV6 gene is located in a region on the short
arm of chromosome 12 that is notable for its frequent
involvement in chromosomal translocations associated with
hematologic malignancies. Around 50 different transloca-
tions involving ETV6 have been reported, involving around
30 partner genes.11 Alternate functional domains of ETV6 are
represented in these fusions. For example, fusions with
JAK212 and RUNX113 involve the PNT domain of ETV6, while
MN1 fusions involve the ETS domain.14 Moreover, diverse
molecular mechanisms can contribute to the pathogenesis of
leukemia resulting from ETV6 fusion, including mislocaliza-
tion of partner kinases or functional disruption of partner
transcription factors.3,9 Interestingly, in many cases, leukemic
cells harboring ETV6 translocations possess no functional
ETV6 protein due to deletion of the wild-type ETV6
allele,13,15,16 specific point mutations leading to truncated
unstable forms of ETV6,17 or dominant negative effects of the
fusion protein over normal ETV6 function.11 This observation
suggests a negative regulatory role for ETV6 within the
hematopoietic transcriptional hierarchy, underpinning a like-
ly tumor suppressor function for this protein.
Targeted knockout of Etv6 in mice resulted in embryonic
lethality at the E10.5-11.5 stage of development due to apopto-
sis of mesenchymal and neural cells and defective yolk sac
angiogenesis.2 Further analysis using chimeric mice revealed
that Etv6 was essential for the establishment of definitive
hematopoiesis in the bone marrow.18 Consistent with these
findings, knockdown of etv6 in Xenopus revealed a requirement
for this gene in the formation of the first definitive hematopoi-
etic stem cells in the dorsal aorta.19 Conditional knockout of
Etv6 in adult mice identified an essential role in survival of adult
hematopoietic stem cells (HSCs) within the hematopoietic
niches.20 However, ablation of Etv6 after lineage commitment
did not affect adult hematopoiesis, except for specific matura-
tion defects in the megakaryocyte lineage.20 In contrast, trans-
genic mice expressing human ETV6 under control of the Gata1
promoter showed accelerated proliferation of early erythroid
progenitors, and increased erythroid differentiation.21 
Zebrafish is an established model for the study of
hematopoiesis, showing broad conservation with mammalian
species, including distinct primitive and definitive waves of
development.22 Zebrafish primitive hematopoietic progenitors
are initially derived from hemangioblasts within the lateral
plate mesoderm,22 and express early hematopoietic genes, such
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Chromosomal translocations involving fusions of the human ETV6 (TEL1) gene occur frequently in hematologic malig-
nancies. However, a detailed understanding of the normal function of ETV6 remains incomplete. This study has
employed zebrafish as a relevant model to investigate the role of ETV6 during embryonic hematopoiesis. Zebrafish pos-
sessed a single conserved etv6 ortholog that was expressed from 12 hpf in the lateral plate mesoderm, and later in
hematopoietic, vascular and other tissues. Morpholino-mediated gene knockdown of etv6 revealed the complex contri-
bution of this gene toward embryonic hematopoiesis. During primitive hematopoiesis, etv6 knockdown resulted in
reduced levels of progenitor cells, erythrocyte and macrophage populations, but increased numbers of incompletely dif-
ferentiated heterophils. Definitive hematopoiesis was also perturbed, with etv6 knockdown leading to decreased ery-
throcytes and myeloid cells, but enhanced lymphopoiesis. This study suggests that ETV6 plays a broader and more
complex role in early hematopoiesis than previously thought, impacting on the development of multiple lineages. 
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ABSTRACT
as scl and ikaros.23,24 From these progenitors, foci for myeloid
(spi1) and erythromyeloid (gata1, spi1) generation are estab-
lished.25,26 Rostrally, macrophage cells expressing lysozyme
(lyz) are produced,27 and caudally there is production of ery-
throid cells expressing β-embryonic globin (β-e-g)28 and het-
erophilic granulocytes expressing myeloperoxidase (mpo) and
matrix metalloproteinase 9 (mmp9).29,30 Finally, from the dorsal
aorta emerge definitive hematopoietic stem cells (HSCs)
expressing c-myb.31 Following a transient phase within the
caudal hematopoietic tissue,31 these HSCs seed the develop-
ing kidney, which becomes the principal site of
hematopoiesis, and the thymus. Here early ikaros+ lym-
phoid precursors yield mature rag1+ T cells.24,32
In previous studies, we and others have shown that
zebrafish is susceptible to the effects of the ETV6-JAK233,34
and ETV6-AML135 oncogenes, which has validated this
organism as a useful model for the study of leukemogenesis
as well as ETV6.  Here we have taken further advantage of
this model to investigate the function of ETV6 during
embryogenesis. This has identified several distinct roles for
ETV6 in embryonic hematopoiesis with implications for
understanding its role in leukemogenesis.  
Methods
Zebrafish maintenance and manipulation
All work involving zebrafish was approved by the Deakin
University Animal Ethics Committee. Wild-type zebrafish stocks
were maintained using standard husbandry practices, as
described.34 Two anti-sense morpholinos (Gene Tools) targeting
zebrafish etv6 were used: a splice-blocking morpholino targeting
the exon II/intron II splice junction (SSmo: 5’-ACACAGAAAAT-
GCAGATTTACCTTA) and one targeting the 5’ untranslated
region (UTRmo: 5’-TCTTGTGTTTCCACTTTCCTCTCCT), as
well as one targeting the lycat gene (5’-CTGAACACACACACT-
GACCGAAGC),36 and a control scrambled morpholino (Co: 5’-
CCTCTTACCTCAGTTACAATTTATA). In addition, morpholi-
no-resistant mRNA encoding Flag-tagged etv6 was generated by in
vitro transcription, as described.33 Embryos were microinjected at
the 1 cell stage with SSmo (8 fmol) and UTRmo (16 fmol) alone or
in combination with the morpholino-resistant etv6mRNA (0.6 ng)
using finely drawn capillaries, and raised at 28°C in egg water
(2.5% (w/v) Na2HPO4; pH 6.0-6.3) containing 0.003% (w/v) 1-
phenyl-2-thiourea to inhibit pigment formation.
RT-PCR and Q-RT-PCR
Total RNA was isolated from pools of 30 whole wild-type or
morphant zebrafish embryos at different developmental time
points using TRIzol (Invitrogen), except for c-myb analysis when
embryos were manually dissected into rostral and caudal seg-
ments. The RNA was reverse transcribed to cDNA using an iScript
cDNA synthesis kit (Bio-Rad). To confirm the effectiveness of the
splice site blocking morpholino, PCR was performed using GoTaq
Green Master Mix (Promega) and primers specific for exon 1 (5’-
CCGGAAGGTGTTAACCATCG) and exon 3 (5’-GAGGAAGTG-
GAGTTTGGCAGTG) of the etv6 gene. Parallel amplification of
the β-actin gene was used as a control, as described.37 To quantify
the relative expression of key hematopoietic genes, Q-RT-PCR
was performed using iQ SYBR Green Supermix (Bio-Rad) and
gene-specific primers detailed in Online Supplementary Table S1. All
reactions were performed with 5 replicates using the Agilent
Strategene MX3000P system, with data analyzed using the Livak
method38 and expressed as a fold change normalized to the β-actin
housekeeping gene, as described.25
WISH and DWISH
Whole-mount in situ hybridization (WISH) was performed on
dechorionated embryos using digoxygenin (DIG)-labeled anti-
sense probes, as described previously,34 with sense probes used in
parallel as a negative control. For etv6, a probe encompassing the
full-length transcript (1657 bp) was used.33 Double WISH was car-
ried out essentially as described.39 Briefly, embryos were
hybridized with an scl probe labeled with fluorescein-UTP and a
etv6 probe labeled with DIG-UTP. The scl probe was detected first
using an anti-fluoroscein alkaline phosphatase conjugate (Roche)
and Fast Red (Roche) as a substrate. After removing the first anti-
body with acid treatment (0.1 M glycine-HCl pH 2.2, 0.1%
Tween-20), the etv6 probe was then detected using an anti-DIG
alkaline phosphatase conjugate (Roche) and NBT/BCIP (Roche) as
a substrate.
Histochemical staining
To detect proliferation, embryos were incubated in 10 mM BrdU
(Sigma) in Danieau water at 4°C for 20 min, rinsed and incubated
at 28.5°C for 5 min, before staining for BrdU incorporation, as
described.40 To detect apoptotic cells, embryos were incubated in 5
μg/mL acridine orange (Sigma) for 20 min, washed 8 times in egg-
water and examined immediately under UV light or subjected to
staining with anti-caspase 3 (BD Bioscience), as described.40
Results
Characterization of teleost etv6 genes
Consistent with other studies,41,42 extensive bioinformat-
ics analyses identified a single etv6 gene in both zebrafish
and pufferfish, with the encoded protein showing high con-
servation to mammalian ETV6 proteins, particularly within
the PNT and ETS domains where overall identity was more
than 80% and more than 90%, respectively (Online
Supplementary Figure S1A). Teleost etv6 genes showed con-
served splicing (Online Supplementary Figure S1B) and synte-
ny (Online Supplementary Figure S1C) with human ETV6,
with the encoded etv6 proteins forming a clade with other
vertebrate ETV6 proteins, which was distinct from the
closely related ETV7 and SPDEF (SAM pointed domain con-
taining ETS transcription factor) (Online Supplementary
Figure S1D).
Embryonic expression profile of etv6 gene in zebrafish
To gain further insight into the role of ETV6 during
embryogenesis, the spatio-temporal expression profile of
zebrafish etv6 was investigated by whole-mount in situ
hybridization using a full-length anti-sense probe.
Transcripts of etv6 were evident in 1 cell embryos (Figure
1A), indicative of maternal derivation. By 12 hpf, this was
replaced by zygotic expression restricted to bilateral stripes
corresponding to the lateral plate mesoderm (LPM) (Figure
1B), which contains precursors for both blood and vascula-
ture.22 By 18 hpf staining was seen in the LPM-derived ante-
rior lateral mesoderm (ALM), pronephric duct and posteri-
or intermediate cell mass (pICM) (Figure 1C and D), the
sites of myeloid and erythromyeloid progenitor produc-
tion, respectively, during the transient primitive wave of
zebrafish hematopoiesis.43 The observed etv6 expression
pattern was similar to that previously described for scl.44
Therefore, double in situ hybridization was performed
with probes for both etv6 and scl. This indicated that etv6
was expressed in a subset of scl positive cells at this time
point (Figure 1E1-E3). A similar pattern of expression was
observed at 24 hpf (Figure 1F), but extending to the nascent
P. Rasighaemi et al.
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pICM-derived posterior blood island (PBI). From 48 hpf,
weak etv6 expression was detected in the vasculature, par-
ticularly the inter-segmental vessels between successive
somites, the caudal hematopoietic tissue (CHT), a transient
secondary site of hematopoiesis, as well as anteriorly
(Figure 1G and H). By 72 hpf, etv6 expression was mostly
anterior, including in the tectum, cerebellum, thymus, as
well as in the developing gut and kidney, the latter being
the ultimate site of definitive hematopoiesis (Figure 1I-J).
This pattern was largely maintained up to 6 dpf, when
additional expression was also observed within optic sen-
sory epithelium (Figure 1K). No staining was observed
using a sense probe as a control (Figure 1L-N). Blood and
vasculature are derived from a common precursor, the
hemangioblast,23 which can be specifically ablated with a
morpholino targeting lycat.36 Injection of this morpholino
resulted in a drastic reduction in the level of both scl (Figure
1O and P) and etv6 (Figure 1Q-T), the latter quantified by
Q-RT-PCR at 3.6-fold (P<10-4). This collectively suggests
that etv6 is expressed in hemangioblast-derived cells and
likely participates in zebrafish embryonic development,
including hematopoiesis.
Targeted knockdown of zebrafish etv6
To investigate the potential involvement of etv6 during
zebrafish embryogenesis, an anti-sense morpholino medi-
ated gene knockdown strategy was used. Two independent
morpholinos were used to verify the specificity of the phe-
notypes observed: one targeting sequences upstream of the
etv6 start codon (UTRmo) and the other targeting the donor
splice-site for exon 2 (SSmo) (Figure 1U). RT-PCR using
primers for exon 1 and 3 confirmed robust inhibition of
splicing in the SSmo-injected embryos (Figure 1V), with Q-
RT-PCR quantifying this as a highly significant 10.4-fold
decrease (P<10-14). An alternatively-spliced product was also
detected, the sequencing of which revealed it to represent a
complex splice product with retained intronic sequence and
use of an alternate exon, which would encode just the first
12 residues of etv6, followed by 35 novel residues before a
stop codon (Figure 1W).
ETV6 regulates embryonic hematopoiesis
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Figure 1. Expression of the zebrafish etv6
gene during embryonic development and its
targeted knockdown using morpholinos.   
(A-Q) Whole-mount in situ hybridization
analysis of etv6 expression. Zebrafish
embryos, either wild-type (A-N) or injected
with control morpholino (Co mo) (O, Q, S) or
lycat mo (lyc mo) (P, R, T), at the develop-
mental time points indicated. These were
hybridized separately with anti-sense etv6
probes (A-D, F-K, Q-T), control (con) sense
etv6 probes (L-N) or scl probes (O-P) with
expression evident as blue staining, or co-
stained for scl (in red) and etv6 (blue) (E1-
E3). (A) Lateral view with the 1 cell to the top;
(B, J and L) dorsal views with rostral to the
left; (C, F, G, I, K, M-P, S-T) lateral views; (Q-R)
oblique lateral views with anterior to the left;
and (D and E1-E3) represent dorsal views of
flat-mount embryos, the latter representing
close-up views of regions equivalent to those
boxed in (D), with etv6 staining indicated
with the white arrows, while (H) is a cross-
section. LPM: lateral plate mesoderm; ALM:
anterior lateral mesoderm; PND: pronephric
duct; pICM: posterior intermediate cell mass;
PBI: posterior blood island; v: vessels; CHT:
caudal hematopoietic tissue; DA: dorsal
aorta; AV: axial vein; t: tectum; c: cerebellum;
th: thymus; k: kidney; g: gut; os: optic sensory
epithelium. (U-W) Morpholino-mediated
knockdown of etv6. Schematic representa-
tion of the zebrafish etv6 locus (middle) and
its targeting with specific anti-sense mor-
pholinos directed to the 5’UTR (UTRmo,
upper), and exon 2/intron 2 splice-site
(SSmo, lower) (U). Exonic sequence is dis-
played in upper case and intronic sequence
in lower case, with binding sites for morpholi-
nos shaded. The relevant encoded amino
acids are shown below with numbering.
Arrows show the location of primers used for
RT-PCR analysis. RT-PCR analysis of total
RNA extracted from SSmo-injected (SSmo)
and control (Co) embryos using specific
primers for etv6 and β-actin as indicated (V).
The arrow and arrowhead indicate the posi-
tions of wild-type and novel etv6 transcripts,
respectively, relative to a size marker. The
structure of the alternatively-spliced tran-
script is shown, including relevant nucleotide
and encoded amino acid sequences derived
from an extended exon 2 and the use of the
alternate exon 1b (W). 
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Zebrafish etv6 is involved in primitive hematopoiesis
Examination of embryos injected with either morpholino
by light microscopy revealed no overt developmental dis-
ruption compared to control embryos, apart from a mild
anemia. To further investigate the role of etv6 during
hematopoiesis, specific blood lineage markers were investi-
gated. At 14 hpf, etv6 and control morphant embryos
showed equivalent expression of scl (Figure 2A and B), a
marker of hemangioblasts,45 and gata1 (Figure 2C-F), an
early erythroid marker.26 However, by 20 hpf the scl expres-
sion pattern was altered in etv6 morphant embryos, with
increased expression rostrally and dorsally (Figure 2G-I, W),
but reduced expression in the pICM (Figure 2K-M, X). Both
of these phenotypes were able to be rescued by co-injection
of morpholino-resistant etv6 mRNA (Figure 2J, N, W-X). A
significant decrease in gata1 expression was also observed
within the pICM at the same time point (Figure 2O-Q,Y),
which could also be rescued (Figure 2R and Y). Finally, β-
embryonic globin (β-e-g), a late erythroid marker,28 was simi-
larly reduced in morphant embryos (Figure 2S-U, Z).
Quantitative RT-PCR (Q-RT-PCR) expression analysis con-
firmed significantly reduced expression of both gata1 and β-
e-g, but also revealed increased expression of erythropoietin
(epo), indicating that defective epo signalling was not
responsible (Figure 2V).
At 36 hpf, morphant signaling embryos showed signif-
icantly increased expression of gata1 (Figure 3A-C), but β-
e-g expression (Figure 3D-F) and O-dianisidine staining of
hemoglobin (Figure 3G-I) were both decreased. Analysis
with Q-RT-PCR confirmed the increased gata1 and
reduced β-e-g levels at this time point, with epo levels no
longer statistically different to controls (Figure 3J).
Differential blood cell counts at 48 hpf indicated a statis-
tically-significant increase in pro-erythroblasts (Figure
P. Rasighaemi et al.
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Figure 2. Knockdown of zebrafish etv6
disrupts primitive hematopoiesis. (A-
U,W-Y) WISH analysis of control (Co),
morphant (SSmo, UTRmo) and rescued
(Res) embryos for expression of scl (A-
B, G-N, W-X), gata1 (C-F, O-R, Y), β-e-g
(S-U,Z) at the times indicated, with
quantitation of dorsal scl (W), caudal
scl (X), total gata1 (Y) and total β-e-g (Z)
at 20 hpf expressed as mean relative
area of expression ± SEM (*: P<0.05).
Regions of altered staining are indicat-
ed with the arrows and arrowheads. (V)
Q-RT-PCR analysis of RNA extracted
from control and SSmo-injected
embryos for the expression of gata1, β-
e-g and epo at 20 hpf, expressed as
mean fold change in morphant relative
to control embryos ± SEM from 5 repli-
cates  (*: P<0.05). 
Figure 3. Effect of etv6 knockdown on
erythroid and other blood cells.  (A-I)
WISH and histochemical analysis of
control (Co) and morphant (SSmo,
UTRmo) embryos for expression of
gata1 (A-C) and β-e-g (D-F) and O-dian-
isidine staining of hemoglobin (G-I) at
36 hpf, with the proportion of embryos
affected shown. (J) Q-RT-PCR analysis
of RNA extracted from control and
SSmo-injected embryos for the expres-
sion of epo, β-e-g and gata1 at 36 hpf.
(K-L) Analysis of Wright-Giemsa
stained blood smears from 48 hpf
SSmo-injected and control embryos by
differential quantitation (K) and light
microscopy (L). Erythro: erythrocytes;
proEB: pro-erythroblasts; Mono/Mac:
monocyte/macrophages; Hetero: het-
erophils (*: P<0.05).  
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3K), but no alterations in morphology were observed
(Figure 3L).
The myeloid compartment was examined by analysis of
spi1, an early pan-myeloid marker,25 lysozyme (lyz), a marker
of early macrophages that develop rostrally and later het-
erophils,27 and mmp9, a marker of various cell populations
including heterophils.30 At 14 hpf, spi1 expression was nor-
mal in etv6 morphants (Figure 4A-D). However, by 20 hpf
there was a significant decrease in the number of cells
expressing spi1 (Figure 4E-H) or lyz (Figure 4I-L) in the ros-
tral part of the embryo. In contrast, a substantial increase in
expression of mmp9 in the region around the cloaca was
observed (Figure 4M-P). Histochemical analysis for
myeloperoxidase (Figure 4Q-S), and Sudan Black (Figure 4T-
V), which specifically stain heterophils,29 confirmed
increased numbers of these cells at 31 hpf. Analysis of blood
smears revealed an increased proportion of heterophils in
morphants (Figure 3K), although a large proportion of these
showed incomplete differentiation (Figure 4W-X). 
Zebrafish etv6 affects definitive hematopoiesis
To explore the role of etv6 during definitive
hematopoiesis, etv6 morphants were examined using a
range of specific molecular markers. Knockdown of etv6 led
to increased expression of runx146 at 36 hpf (Figure 
5A-B, I’) that reached significance at 48 hpf (Figure 5C-D, I’)
and c-myb31 from 36 hpf to 3 dpf (Figure 5E-H, I-K, I’), when
c-myb positive precursors migrate from the CHT to the thy-
mus. Q-RT-PCR analysis performed separately for the ros-
tral and caudal regions of embryo showed that the
increased expression was restricted to the caudal region
(Figure 5J’). Conversely, by 5 dpf, c-myb was slightly
reduced in the CHT, thymus and kidney of morphant
embryos (Figure 5L-N, J’), indicative of a disruption of pro-
genitor cells. Morphant embryos were also overtly anemic
by light microscopy, which was confirmed by reduced O-
dianisidine staining at 4 dpf (Figure 5O-Q) and β-e-g expres-
sion at 5 dpf (Figure 5U-W, J’). Interestingly, this was despite
increased gata1 at 5 dpf (Figure 5R-T), confirmed by Q-RT-
PCR at 5 dpf when epo expression was also increased and
epor expression was normal (Figure 5J’), confirming the
reduced erythroid differentiation was not due to defective
epo signaling. Morphant embryos maintained significantly
increased numbers of circulating pro-erythroblasts (Figure
ETV6 regulates embryonic hematopoiesis
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Figure 4. Knockdown of etv6 dis-
rupts primitive myelopoiesis.  
(A-P) WISH analysis of morphant
and control embryos for expres-
sion of spi1 at 14 hpf (A-D) and
20 hpf (E-H), lyz and mmp9 at 20
hpf (I-L and M-P, respectively),
with quantitation of relative
expression area of spi1 at 14 hpf
(D), the number of positive cells
for spi1 and lyz expression at 20
hpf (H and L, respectively) and
expression area of mmp9 at 
20 hpf (P), presented as mean 
± SEM (*:P<0.05). (Q-V)
Histochemical staining for
myeloperoxidase activity (mpx)
(Q-S) and Sudan Black B (SBB) 
(T-V) at 31 hpf on SSmo-injected
and control embryos, with the
number of positive cells present-
ed as mean ± SEM (S and V,
respectively) (*: P<0.05).  (W-X)
Morphological characterization
of heterophils. Stages of het-
erophil differentiation observed
in 48 hpf blood smears by light
microscopy (W: i-iv), and their
quantitation in SSmo injected
and control embryos (X). 
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I J K L
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5K’-L’), although these are largely derived from primitive
erythropoiesis at this time point.47 Analysis of BrdU incor-
poration revealed increased proliferation within the CHT at
3 dpf (Figure 5X-B’), whereas staining with acridine orange
(Figure 5C’ and D’) and anti-caspase 3 (Figure 5E’-H’) indi-
cated enhanced apoptosis in this region at 4-5 dpf.
To examine the role of etv6 in definitive myeloid cell
development, the myeloid specific markers, lyz and mmp9,
were also examined at 5 dpf. Interestingly, morphant
embryos showed a modest expansion of lyz+ cells (Figure
6A-C, E), which could be rescued by co-injection of mor-
pholino-resistant etv6 mRNA (Figure 6D and E). In contrast,
there was a reduction of mmp9+ cells (Figure 6F-I), with this
differential effect confirmed by Q-RT-PCR analysis of the
respective genes (Figure 6W). Blood examination at 5 dpf
revealed elevated numbers of monocyte/macrophages in
morphant embryos compared to controls, while in contrast
circulating heterophils were lessened in morphants,
although this did not reach significance (Figure 5K’ and L’).
Finally, lymphopoiesis was investigated through evaluation
of the lymphoid markers ikaros24 and rag1.32 In etv6 mor-
phant embryos expression of ikaros was increased at 3 dpf
(Figure 6J-M) and 5 dpf (Figure 6N-Q). Expression of the late
lymphoid marker rag1 was also increased at 5 dpf (Figure
P. Rasighaemi et al.
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Figure 5. Knockdown of etv6
affects definitive HSC and ery-
throid compartments. (A-N, R-W)
WISH analysis of the indicated
morphant and control embryos for
the expression of runx1 at 36 hpf
(A-B) and 48 hpf (C-D), c-myb at
36 hpf (E-F), 48 hpf (G-H), 3 dpf (I-
K) and 5 dpf (L-N), gata1 (R-T) and
β-e-g (U-W) at 5 dpf. (O-Q, X-F’)
Histochemical staining of the indi-
cated morphant and control
embryos to detect hemoglobin
using O-dianisidine hemoglobin
(O-dia) (O-Q), proliferation using
BrdU incorporation (X-B’) and
apoptosis using acridine orange
(AO) (C’-D’) and anti-caspase 3 (E’-
H’) at the times shown, with the
number of BrdU-positive cells ±
SEM shown (B’). 
(I’-J’) Q-RT-PCR analysis of runx1
and c-myb at 36 hpf and 48 hpf,
total (I’), and rostral and caudal c-
myb at 3 dpf, total c-myb at 4 dpf,
and c-myb, gata1, epo and epor at
5 dpf (J’), expressed as fold
change in SSmo-injected relative
to control embryos ± SEM from 5
replicates (*: P<0.05). (K’-L’)
Analysis of Wright-Giemsa stained
blood smears from 5 dpf mor-
phant and control embryos by dif-
ferential quantitation (K’) and
light microscopy (L’): designations
as described for Figure 3K, with
the addition of Lympho (lympho-
cytes) (*: P<0.05). 
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6R-T, V), with this phenotype able to be rescued by mor-
pholino-resistant etv6 mRNA (Figure 6U and V). The
increased expression of lymphoid genes in morphants was
confirmed by Q-RT-PCR analysis (Figure 6X). In addition,
morphant embryos showed higher lymphocyte numbers in
peripheral blood smears at 5 dpf (Figure 5K’ and L’).
Moreover, no difference was observed in expression of the
thymic epithelium marker foxn1 (Figure 6Y and Z). This col-
lectively indicates enhanced lymphopoiesis in etv6 mor-
phants.
Discussion
Despite the frequent involvement of the ETV6 gene in
hematologic malignancies, much remains to be learned
about the role of ETV6 during normal hematopoietic
development. This is partly related to the embryonic
lethality of Etv6-knockout mice due to a failure in angio-
genesis,2,20 which has complicated more detailed studies.
Since embryonic development in zebrafish is not depend-
ent on vasculogenesis, we hypothesized that this organ-
ism would be a useful alternative vertebrate model for
investigating the function of ETV6 during embryogenesis.
This study has characterized the zebrafish etv6 gene, and
delineated its role during embryonic hematopoiesis,
where it acts at multiple levels to influence the production
of blood and immune cells. 
In agreement with other work,41,42 bioinformatic analysis
revealed that the zebrafish possessed a single etv6 protein
with high sequence homology with other vertebrate ETV6
proteins, especially within the PNT and ETS domains, indi-
cating functional conservation. Expression studies showed
zebrafish etv6 transcripts were found to be initially mater-
nally-derived, with specific zygotic expression evident from
12 hpf in the LPM in a subset of scl positive
hemangioblasts.22 By 18 hpf, expression was seen in the
anterior lateral mesoderm (ALM) and posterior intermedi-
ate cell mass (pICM), the sites of primitive myelopoiesis
and erythropoiesis,43 and by 24 hpf staining was also
observed in the nascent posterior blood island (PBI), and
later in vessels. At 3 dpf, etv6 expression was evident in the
thymus, the site of lymphopoiesis, and later in the develop-
ing kidney, the site of definitive hematopoiesis. Expression
was drastically reduced in embryos in which heman-
gioblasts were ablated. This is consistent with the expres-
sion studies in Xenopus,19 mice18 and in various hematopoiet-
ic cell lines,18 suggesting a conserved role in blood and
immune cell development across vertebrates. Expression
also overlapped with that for the related etv7 gene.48
The earliest zebrafish hematopoietic cells are derived
from hemangioblasts in the LPM at 12 hpf,22 characterized
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Figure 6. Knockdown of etv6 affects
definitive myeloid and lymphoid com-
partments. (A-V, Y-Z) WISH analysis of
control, morphant and rescued embryos
showing representative expression of lyz
in the tail (A-E) and mmp9 in the tail (F-I)
at 5 dpf, as well as ikaros at 3 dpf (J-M)
and 5 dpf (N-Q), rag1 at 5 dpf (R-V), and
foxn1 at 5 dpf (Y-Z) in the thymus. The
total number of lyz+ and mmp9+ cells in
the embryos are presented as mean ±
SEM (E and I, respectively), and the area
of ikaros and rag1 staining quantified rel-
ative to eye size, and expressed as mean
± SEM (M, Q and U, respectively) 
(*: P<0.05). (W-X) Q-RT-PCR analysis of
morphant and control embryos for the
expression of mmp9 and lyz at 5 dpf (W)
or ikaros and rag1 at 3 or 5 dpf as indi-
cated (X), expressed as fold change in
SSmo-injected relative to control
embryos ± SEM from 5 repeats 
(*: P<0.05). 
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by the expression of markers for hematopoietic progeni-
tors, such as scl, as well as those for early myeloid (spi1) and
erythroid (gata1) populations.23,25,26 Morpholino-mediated
knockdown of etv6 did not alter the expression of early
hematopoietic markers, suggesting that hematopoietic cell
specification was etv6-independent. However, at 20 hpf
there was differential effect on scl populations, with an
increase within ventral, non-hematopoietic tissue, but a
reduction of caudal expression in hematopoietic tissue, sug-
gesting that etv6may influence the early hematopoietic pro-
genitor compartment. This would potentially explain the
reduced levels of early (spi1) and late (lyz) myeloid cells ros-
trally, and reduced early (gata1) and late (β-e-g) erythroid
cells caudally. Interestingly, there was a specific increase in
the mmp9+ cells caudally, suggesting that etv6 might also
influence lineage choice during primitive hematopoiesis in
this region. This is the first study demonstrating the
involvement of ETV6 during primitive hematopoiesis, and
is in contrast with previous studies that have reported unaf-
fected yolk sac and fetal liver hematopoiesis in Etv6–/–
mice,2,20 which may represent a genuine difference between
the two species.
Definitive HSCs in zebrafish originate in the dorsal aorta
and migrate first to the CHT before seeding the kidney and
thymus.47 Morphant embryos showed a significant increase
in cells expressing runx1 and c-myb within the dorsal aorta
and CHT, which correlated with increased proliferation in
the latter. However, by 5 dpf, etv6 morphants showed an
overall decrease in c-myb expression, along with increased
apoptosis in this region, suggesting etv6may impact on cell
survival. This is consistent with the failure of Etv6–/– progen-
itors to contribute to bone marrow hematopoiesis in
chimeric mouse,18 and the loss of bone marrow HSCs in
mice with Etv6 specifically inactivated in the hematopoietic
compartment.20 Interestingly, etv6 morphant Xenopus
embryos exhibited a more severe phenotype, with HSCs
completely ablated, although this was secondary to a severe
defect in artery formation.19 An increase in lymphopoiesis
was also observed in zebrafish etv6morphants concomitant
with the loss of c-myb+ cells, suggesting that etv6-deficiency
may result in preferential differentiation down this lineage.
This observation may be of clinical relevance, providing
one possible explanation for the high propensity of ETV6
fusions in lymphoid malignancies.
The role of ETV6 in erythropoiesis has remained contro-
versial. Previous work has shown that selective excision of
Etv6 in the erythroid lineage of mice failed to impact on ery-
thropoiesis.20 However, other data have demonstrated that
overexpression of ETV6 enhanced erythroid differentiation
in cell models,49 as well as leading to increased erythroid
precursors, accelerated differentiation and augmented glo-
bin expression in mice transgenic for ETV6.21 Our data are
consistent with the latter studies, with etv6 morphants
showing an initial decrease in gata1 expression, followed by
a sustained increase in expression. However, despite this
increase in early erythroid cells (and a parallel induction of
epo) etv6morphants remained anemic, with decreased β-e-g
expression and increased erythroblasts in the blood. This
collectively suggests a role for etv6 in the regulation of red
blood cell maturation. Expression of etv7, which also con-
tributes to red blood cell maturation,48 was reduced in etv6
morphants. This suggests the two genes may act co-ordi-
nately in this process.
Our data also revealed that etv6 influences the differenti-
ation of zebrafish heterophils, the piscine neutrophil equiv-
alent. Morphant embryos showed incomplete heterophil
differentiation at 48 hpf and reduced numbers of mmp9+
heterophils at 5 dpf. Close examination of the published
study using chimeric mice revealed that while Etv6–/– cells
were able to contribute to all definitive hematopoietic line-
ages, the granulocyte/macrophage lineage was under-repre-
sented,18 and the study on the hematopoietic-specific dis-
ruption of Etv6 described reduced neutrophils, despite nor-
mal red cell and lymphocyte numbers.20 A role for ETV6 in
regulating myeloid differentiation might also be relevant in
the context of ETV6 fusions in myeloid malignancies.
Finally, ETV6 has been implicated in angiogenesis, with
yolk sac angiogenesis disrupted in Etv6–/– mice,2 and arterial
differentiation ablated in etv6 morphant Xenopus embryos
due to loss of VEGFA expression.19 A more subtle defect
was recently reported following etv6 knockdown in
zebrafish embryos, with aberrant trajectories and stalled
sprouts observed during intersegmental vessel (ISV) forma-
tion.50 To verify this, etv6 SSmo was injected into flk1:gfp
transgenic embryos, which resulted in similar subtle ISV
defects (Online Supplementary Figure S2A-C), confirming this
distinct angiogenic role, which may be an indirect conse-
quence of the altered scl expression seen in etv6morphants.
No other vascular defects were observed (data not shown).
Moreover, overexpression of etv6 had no significant effect
on circulation (Online Supplementary Figure S2D).
Collectively, our data suggest that ETV6 participates in both
blood and, to a lesser extent, vessel development, consistent
with their common derivation from the hemangioblast, and
the expression of ETV6 in both lineages. 
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